The US Food and Drug Administration (FDA) licensed Remdesivir, the drug Trump used when suffering from Covid-19, to treat patients.

Producer Gilead Sciences on October 22 said the antiviral drug Remdesivir, sold as Veklury, was approved by the FDA in emergency cases in May. Remdesivir was approved or approved for temporary use.

"In the US, Veklury is indicated for adults and pediatric patients 12 years of age and older and weighing at least 40 kg for the treatment of Covid-19 in case of hospitalization. Veklury should be used only in hospital or muscle cases.

Remdesivir is currently the first and only fully approved Covid-19 treatment in the US.

"It's unbelievable that less than a year since the first case of infection, an FDA-approved treatment is available to all patients in need," said Daniel O'Day, director

Earlier this month, a global study sponsored by the World Health Organization (WHO) found that Remdesivir did not help patients survive or recover faster, but a US study found the drug shortened 1

The FDA uses data submitted by drug manufacturers when they review licensing.

The FDA also reviewed two other studies.

"The approval is supported by data from many clinical trials that the agency has rigorously evaluated and represents a key scientific milestone in the Covid-19 pandemic," said Dr. Stephen Hahn, commissioner.

The drug was approved as the US recorded more than 8.6 million infections and more than 228,000 deaths.